These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
58 related articles for article (PubMed ID: 8239539)
1. Chemoresistant cell lines: morphonuclear characteristics and chemosensitivity development during long-term culture. Pauwels O; Kiss R Anticancer Res; 1993; 13(5A):1593-9. PubMed ID: 8239539 [TBL] [Abstract][Full Text] [Related]
2. Digital morphonuclear analyses of sensitive versus resistant neoplastic cells to vinca-alkaloid, alkylating, and intercalating drugs. Pauwels O; Kiss R Cytometry; 1991; 12(5):388-97. PubMed ID: 1935454 [TBL] [Abstract][Full Text] [Related]
3. Computerized morphonuclear analyses of Feulgen-stained nuclei from 11 chemosensitive and from 11 chemoresistant neoplastic cell lines. Pauwels O; Kiss R Anal Cell Pathol; 1994 Oct; 7(3):235-50. PubMed ID: 7531485 [TBL] [Abstract][Full Text] [Related]
4. Establishment of doxorubicin-resistant human bladder cancer cell line (BUI-87/ADMR) and its mechanism of multidrug resistance. Guo H; Lu G; Xiong X; Dong J; Liu S Chin Med J (Engl); 1997 Mar; 110(3):167-72. PubMed ID: 9594332 [TBL] [Abstract][Full Text] [Related]
5. Concomitant decrease of resistance and modifications of the cytoskeleton after all-trans retinoic acid and phorbol ester treatments in a navelbine-resistant bladder carcinoma cell line. Debal V; Breillout F; Manfait M Anticancer Res; 1997; 17(2A):1147-54. PubMed ID: 9137463 [TBL] [Abstract][Full Text] [Related]
6. Combined Fourier transform infrared and Raman spectroscopic approach for identification of multidrug resistance phenotype in cancer cell lines. Krishna CM; Kegelaer G; Adt I; Rubin S; Kartha VB; Manfait M; Sockalingum GD Biopolymers; 2006 Aug; 82(5):462-70. PubMed ID: 16493658 [TBL] [Abstract][Full Text] [Related]
8. Sensitivity of drug-resistant human ovarian tumor cell lines to combined effects of tumor necrosis factor (TNF-alpha) and doxorubicin: failure of the combination to modulate the MDR phenotype. Safrit JT; Berek JS; Bonavida B Gynecol Oncol; 1993 Feb; 48(2):214-20. PubMed ID: 8428693 [TBL] [Abstract][Full Text] [Related]
9. Digital cell image analysis of verapamil-induced effects in chemosensitive and chemoresistant neoplastic cell lines. Etiévant C; Pauwels O; Kiss R J Cancer Res Clin Oncol; 1993; 120(1-2):76-84. PubMed ID: 8270613 [TBL] [Abstract][Full Text] [Related]
10. A comparison of the modulation of antiblastics cytotoxicity by verapamil and dipyridamole in a human colon carcinoma cell line. Berti E; Carrara M; Ragazzi E; D'Ancona S; Berti T Int J Oncol; 1999 Jul; 15(1):155-60. PubMed ID: 10375609 [TBL] [Abstract][Full Text] [Related]
11. Testing of a chemosensitivity screening method on sensitive and resistant breast tumoral epithelial cell lines. Colomb E; Martin PM Anal Cell Pathol; 1994 Feb; 6(2):105-16. PubMed ID: 8167093 [TBL] [Abstract][Full Text] [Related]
12. A senescence-like phenotype distinguishes tumor cells that undergo terminal proliferation arrest after exposure to anticancer agents. Chang BD; Broude EV; Dokmanovic M; Zhu H; Ruth A; Xuan Y; Kandel ES; Lausch E; Christov K; Roninson IB Cancer Res; 1999 Aug; 59(15):3761-7. PubMed ID: 10446993 [TBL] [Abstract][Full Text] [Related]
13. Effect of pO2 on antitumor drug cytotoxicity on MDR and non-MDR variants selected from the LoVo metastatic colon carcinoma cell line. Lelong-Rebel I; Brisson C; Fabre M; Bergerat JP; Rebel G Anticancer Res; 2008; 28(1A):55-68. PubMed ID: 18383825 [TBL] [Abstract][Full Text] [Related]
14. Analysis of microsatellite instability in acquired drug-resistance human tumor cell lines. Picard SF; Franco N; Sergent C; Chauffert B; Lizard-Nacol S Oncol Rep; 2002; 9(5):971-6. PubMed ID: 12168057 [TBL] [Abstract][Full Text] [Related]
15. Prediction of doxorubicin sensitivity in breast tumors based on gene expression profiles of drug-resistant cell lines correlates with patient survival. Györffy B; Serra V; Jürchott K; Abdul-Ghani R; Garber M; Stein U; Petersen I; Lage H; Dietel M; Schäfer R Oncogene; 2005 Nov; 24(51):7542-51. PubMed ID: 16044152 [TBL] [Abstract][Full Text] [Related]
16. Discovery of differentially expressed genes associated with paclitaxel resistance using cDNA array technology: analysis of interleukin (IL) 6, IL-8, and monocyte chemotactic protein 1 in the paclitaxel-resistant phenotype. Duan Z; Feller AJ; Penson RT; Chabner BA; Seiden MV Clin Cancer Res; 1999 Nov; 5(11):3445-53. PubMed ID: 10589757 [TBL] [Abstract][Full Text] [Related]
17. RAIDD expression is impaired in multidrug resistant osteosarcoma cell lines. Yang C; Hornicek FJ; Wood KB; Schwab JH; Mankin H; Duan Z Cancer Chemother Pharmacol; 2009 Aug; 64(3):607-14. PubMed ID: 19125251 [TBL] [Abstract][Full Text] [Related]
19. A serine 37 mutation associated with two missense mutations at highly conserved regions of p53 affect pro-apoptotic genes expression in a T-lymphoblastoid drug resistant cell line. Cinti C; Claudio PP; Luca AD; Cuccurese M; Howard CM; D'Esposito M; Paggi MG; Sala DL; Azzoni L; Halazonetis TD; Giordano A; Maraldi NM Oncogene; 2000 Oct; 19(44):5098-105. PubMed ID: 11042698 [TBL] [Abstract][Full Text] [Related]
20. Evaluation of nuclear morphology in adriamycin sensitive and resistant cells. Komitowski D; Charamella LJ; Dimitrov NV Ann Clin Lab Sci; 1994; 24(3):259-65. PubMed ID: 8048798 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]